Herlev Hospital is a hospital in Herlev, Denmark, close to Copenhagen. The building is 120 metres tall and has 25 floors. It is famous for being Denmark's tallest building. Its modern, functional architecture in bright concrete, glass and bronze-colored aluminum gives a unique impression.

During the past decade, Department of Oncology, Copenhagen University hospital, Herlev conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Oncology, Copenhagen University hospital, Herlev" #1 sponsor was "Herlev Hospital" with 7 trials, followed by "Inge Marie Svane" with 6 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 5 trials sponsored, "Alligator Bioscience AB" with 2 trials sponsored and "Copenhagen University Hospital at Herlev" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Oncology, Copenhagen University hospital, Herlev" #1 collaborator was "Odense University Hospital" with 5 trials as a collaborator, "Herlev Hospital" with 4 trials as a collaborator, "Aarhus University Hospital" with 3 trials as a collaborator, "Aalborg University Hospital" with 2 trials as a collaborator and "Danish Cancer Society" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Department of Oncology, Copenhagen University hospital, Herlev" are "Breast Cancer" (3 trials), "Kidney Cancer" (3 trials), "Neoplasms" (3 trials), "Advanced Renal Cell Carcinoma" (2 trials) and "Anal Cancer" (2 trials). Many other conditions were trialed in "Department of Oncology, Copenhagen University hospital, Herlev" in a lesser frequency.

Most popular intervention types in "Department of Oncology, Copenhagen University hospital, Herlev" are "Drug" (21 trials), "Biological" (15 trials), "Behavioral" (3 trials), "Other" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (2 trials), "DC vaccine" (2 trials), "tumor antigen loaded autologous dendritic cells" (2 trials), "60 Gy/30F" (1 trials) and "66 Gy/33F" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Oncology, Copenhagen University hospital, Herlev" are 33 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Department of Oncology, Copenhagen University hospital, Herlev". 1 are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Department of Oncology, Copenhagen University hospital, Herlev, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Oncology, Copenhagen University hospital, Herlev, 13 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".